Literature DB >> 21401811

TRAF6 directs commitment to regulatory T cells in thymocytes.

Yusuke Shimo1, Hiromi Yanai, Daisuke Ohshima, Junwen Qin, Hidehiko Motegi, Yuya Maruyama, Shohei Hori, Jun-Ichiro Inoue, Taishin Akiyama.   

Abstract

Regulatory T cells (Tregs), a subset of CD4(+) helper T cells, are crucial for immunological self-tolerance. Defect in development or function of Tregs results in autoimmune disease in human and mice. Whereas it is known that Tregs mainly develop in the thymus, the molecular mechanism underlying development of Treg is not fully understood. TRAF6-deficient mice showed a severe defect in the Treg development in thymus. In vitro fetal thymic organ culture experiments indicated that the defect is ascribed to the absence of TRAF6 in thymic cells. Moreover, mixed fetal liver transfer experiments revealed that the development of Foxp3(+) cells differentiated from Traf6(-/-) hematopoietic cells was specifically impaired in the thymus, indicating cell-intrinsic requirement for TRAF6 in the Treg development. On the other hand, TRAF6 is not required for the development of conventional CD4(+) T cell. In addition, TGFβ-dependent induction of Foxp3 in CD4(+) T cells in vitro was not impaired by the absence of TRAF6. Overall, our data indicate that TRAF6 plays an essential role on the commitment of immature thymocytes to thymic Tregs in cell-intrinsic fashion.
© 2011 The Authors. Journal compilation © 2011 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401811     DOI: 10.1111/j.1365-2443.2011.01500.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  22 in total

1.  TNF receptor-associated factor 6 in advanced non-small cell lung cancer: clinical and prognostic implications.

Authors:  Hui Liu; Tiantuo Zhang; Jin Ye; Hongtao Li; Jing Huang; Xiaodong Li; Benquan Wu; Xubing Huang; Jinghui Hou
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-27       Impact factor: 4.553

2.  miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency.

Authors:  Yunjie Lu; Keli L Hippen; Amanda L Lemire; Jian Gu; Weizhi Wang; Xuhao Ni; Parvathi Ranganathan; Bruce L Levine; James L Riley; Carl H June; Laurence A Turka; David H Munn; Ramiro Garzon; Ling Lu; Bruce R Blazar
Journal:  Blood       Date:  2016-08-02       Impact factor: 22.113

3.  Ubiquitin-Dependent Regulation of Treg Function and Plasticity.

Authors:  Yi Dong; Fan Pan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  TRAF family molecules in T cells: Multiple receptors and functions.

Authors:  Tina Arkee; Gail A Bishop
Journal:  J Leukoc Biol       Date:  2019-11-21       Impact factor: 4.962

Review 5.  Treg functional stability and its responsiveness to the microenvironment.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

6.  Regulation of Treg Functions by the Ubiquitin Pathway.

Authors:  Elena Montauti; Deyu Fang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system.

Authors:  Matthew C Walsh; JangEun Lee; Yongwon Choi
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

Review 8.  Ubiquitin-dependent regulation of Foxp3 and Treg function.

Authors:  Joseph Barbi; Drew M Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

Review 9.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

10.  Thymocyte apoptosis drives the intrathymic generation of regulatory T cells.

Authors:  Joanne E Konkel; Wenwen Jin; Brittany Abbatiello; John R Grainger; WanJun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.